Long-term analysis of the palliative benefit of 2-Chlorodeoxyadenosine (2-CdA) for myelofibrosis with myeloid metaplasia
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: L. Faoro, R. Mesa, M. A. Gertz, A. Tefferi
Institution: Mayo Clinic
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2287436164
